Severe aplastic anaemia in the Nordic countries: A population based study of incidence, presentation, course, and outcome

Archives of Disease in Childhood

Volumn 74, Issue 4, 1996, Pages 319-322

  Clausen, Niels ^a,b   Kreuger, Anders ^a   Salmi, Toivo ^a   Storm Mathisen, Ingebjørg ^a   Johannesson, Gudmundur ^a  

^a Nordic Soc Pediat Hematol Oncol   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Aplastic anaemia; Epidemiology; Survival

Indexed keywords

APLASTIC ANEMIA; ARTICLE; CHILD; DENMARK; FEMALE; FINLAND; HUMAN; ICELAND; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NORWAY; PRIORITY JOURNAL; SEX DIFFERENCE; SURVIVAL; SWEDEN;

EID: 0029897696     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.74.4.319     Document Type: Article

References (16)

1. Camitta BM, Thomas ED, Nathan DG, et al. A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood 1979; 53: 504-14.
2. Matloub YH, Brunning RD, Arthur DC, Ramsay NK. Severe aplastic anemia preceding acute lymphoblastic leukemia. Cancer 1993; 71: 264-8.
3. Kaplan EL, Meier P. Non-parametric estimation for incomplete observations. Journal of the American Statistical Association 1958; 53: 457-60.
4. Bayever E, Champlin R, Ho W, et al. Comparison between bone marrow transplantation and antithymocyte globulin in treatment of young patients with severe aplastic anemia. J Pediatr 1984; 105: 920-5.
5. Seip M, Vidnes J. Cyclosporin A in a case of refractory severe aplastic anemia. Scandinavian Journal of Hematology 1985; 34: 228-30.
6. Böttiger LE, Westerholm B. Aplastic anaemia. I. Incidence and aetiology. Acta Paediatr Scand 1972; 192: 315-8.
7. Mary JY, Baumelou E, Guiguet M. Epidemiology of aplastic anemia in France: a prospective multicentric study. Blood 1990; 75: 1646-53.
8. Cartwright RA, McKinney PA, Williams L, et al. Aplastic anaemia incidence in parts of the United Kingdom in 1985. Leuk Res 1988; 12: 459-63.
9. Szklo M, Sensenbrenner LL, Markowitz JA, Weida S. Warm S, Linet MS. Incidence of aplastic anemia in metropolitan Baltimore: a population-based study. Blood 1985; 66: 115-9.
10. Issaragrisil S, Sriratanasatavorn C, Piankijagum A, et al. Incidence of aplastic anemia in Bangkok. Blood 1991; 77: 2166-8.
11. Clausen N. A population study of severe aplastic anemia in children. Incidence, aetiology and course. Acta Paediatr Scand 1986; 75: 58-63.
12. Camitta BM, Doney K. Immunosuppressive therapy for aplastic anemia: indications, agents, mechanisms and results. Am J Pediatr Hematol Oncol 1990; 12: 411-24.
13. Khatib Z, Wilimas J, Wang W. Outcome of moderate aplastic anemia in children. Am J Pediatr Hematol Oncol 1994; 16: 80-5.
14. Nissen C, Gratwohl A, Tichelli A, et al. Gender and response to antilymphocyte globulin (ALG) for severe aplastic anaemia. Br J Haematol 1993; 83: 319-25.
15. Malkin D, Koren G, Saunders EF. Drug-induced aplastic anemia: pathogenesis and clinical aspects. Am J Pediatr Hematol Oncol 1990; 12: 402-10.
16. Baumelou E, Guiguet M, Mary JY. Epidemiology of aplastic anemia in France: a case-control study. I. Medical history and medication use. The French Cooperative Group for Epidemiological Study of Aplastic Anemia. Blood 1993; 81: 1471-8.